MustGrow Biologics Corp.
MGRO.V
TSX
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -3.57M | -179.80K | -334.00K | -526.60K | -533.00K |
Total Depreciation and Amortization | -- | -- | -- | -- | -- |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 1.08M | 859.00K | 662.10K | 710.30K | 692.90K |
Change in Net Operating Assets | -132.00K | -938.50K | -477.50K | -440.70K | -400.70K |
Cash from Operations | -2.62M | -259.40K | -149.50K | -256.90K | -240.70K |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -241.30K | -241.30K | -241.30K | -- | -- |
Issuance of Common Stock | -- | 0.00 | 95.80K | 95.80K | 95.80K |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -176.40K | -176.40K | -105.00K | 71.40K | 71.40K |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -2.79M | -435.70K | -254.50K | -185.60K | -169.40K |